ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
171 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 63 reducing their positions, and 29 closing their positions.
Holders
171
Holders Change
-10
Holders Change %
-5.52%
% of All Funds
4.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
58
Reduced
63
Closed
29
Calls
$14.5M
Puts
$21.5M
Net Calls
-$7.08M
Net Calls Change
+$9.66M
Top Buyers
1 |
SCM
1
Scopia Capital Management
New York
|
$87.8M |
2 |
BC
2
Broadfin Capital
New York
|
$12.6M |
3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$15M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$12.2M |
5 |
5
Goldman Sachs
New York
|
$15.1M |